Markets:

Overview

News

Currencies

International

Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

70.06 -0.00 (-0.00%)

Streaming Delayed Price Updated: 10:09 AM EDT, Jun 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates ↗

July 11, 2024

In a recent letter to investors, Cathie Wood, the CEO of ARK Invest, highlighted the potential of the company's flagship fund, ARK Innovation ETF, despite its recent underperformance.

Via Benzinga

Topics ETFs

Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies

July 10, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A

July 09, 2024

From Twist Bioscience Corporation

Via Business Wire

Key Takeaways From Twist Bioscience Analyst Ratings ↗

June 28, 2024

Via Benzinga

Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today ↗

July 02, 2024

Via Benzinga

Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio? ↗

June 09, 2024

Mid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX, causing analysts to raise their forecasts.

Via Benzinga

Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor

June 06, 2024

From Twist Bioscience Corporation

Via Business Wire

Expert Outlook: Twist Bioscience Through The Eyes Of 6 Analysts ↗

June 05, 2024

Via Benzinga

Breaking Down Twist Bioscience: 5 Analysts Share Their Views ↗

May 06, 2024

Via Benzinga

Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday ↗

June 05, 2024

Via Benzinga

This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

June 05, 2024

Via Benzinga

Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety

June 04, 2024

From Twist Bioscience Corporation

Via Business Wire

Analyst Scoreboard: 5 Ratings For Twist Bioscience ↗

April 10, 2024

Via Benzinga

Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday ↗

June 03, 2024

Via Benzinga

Twist Bioscience to Present at Upcoming Investor Conferences

May 23, 2024

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications

May 13, 2024

From Twist Bioscience Corporation

Via Business Wire

Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗

May 10, 2024

Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today.

Via InvestorPlace

Cathie Wood's Ark Invest Purchases Over $30M of Shopify Shares Amid Q1 Numbers-Driven Plunge; Adds Reddit Shares To Kitty — Offloads Coinbase Stock As Bitcoin Declines ↗

May 08, 2024

On Wednesday, Cathie Wood’s Ark Invest made some significant trades.

Via Benzinga

Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

May 08, 2024

From Twist Bioscience Corporation

Via Business Wire

Cathie Wood's Ark Invest Swoops In To Buy The Palantir Dip — Purchases Stock Worth $29M — Offloads Coinbase Shares Worth Over $15M Amid Softening Bitcoin Price ↗

May 07, 2024

On Tuesday, the Cathie Wood-led Ark Invest made some significant trades.

Via Benzinga

Genomics firm Twist Bioscience's Momentum To Continue Throughout 2024, Analyst Says ↗

May 03, 2024

Twist Bioscience reports strong Q2 earnings, with sales up 25% YoY to $75.3M and orders increasing by 45%. Gross margin expands to 41%. Fiscal year guidance was raised, and William Blair sees continued...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 03, 2024

Via Benzinga

Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday ↗

May 03, 2024

Via Benzinga

TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024 ↗

May 02, 2024

TWST stock results show that Twist Bioscience beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 02, 2024

Via Benzinga

Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results

May 02, 2024

From Twist Bioscience Corporation

Via Business Wire

3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition ↗

April 30, 2024

Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future.

Via InvestorPlace

Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024

April 18, 2024

From Twist Bioscience Corporation

Via Business Wire

Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip ↗

March 28, 2024

Via Benzinga

Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations

March 28, 2024

From Twist Bioscience Corporation

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.